On January 11, 2022, Well Lead Medical Co., Ltd. closed the transaction. The company issued 29,632,218 shares at an issue price CNY 13.48 per share for gross proceeds of CNY 399,442,298.64. The company paid an expenses of CNY 6,627,358.48 in the transaction.

The transaction included participation from Liao Lei for 7,418,397 shares for CNY 99,999,991.56, Guangzhou Ruisheng Private Securities Investment Management Partnership Enterprise (Limited Partnership) - Ruisheng No. 6 Private Securities Investment Fund for 5,044,510 shares for CNY 67,999,994.80, Caitong Fund Management Co., Ltd. for 2,967,359 shares for CNY 39,999,999.32, Zhuhai Jinteng Equity Investment Fund Partnership Enterprise (Limited Partnership) for 2,967,359 shares for CNY 39,999,999.32, Li Yujing for 2,225,519 shares for CNY 29,999,996.12, Huaxi Yinfeng Investment Co., Ltd. for 2,225,519 shares for CNY 29,999,996.12, Cai Zhihua for 2,225,519 shares for CNY 29,999,996.12, Taikang Asset Management Co., Ltd.-Taikang Life Insurance Co., Ltd. Dividend Insurance Product for 1,590,678 shares for CNY 21,442,339.44, UBS AG for 1,483,679 shares for CNY 19,999,992.92, and Shanghai Wuxu Asset Management Co., Ltd. - Wuxu Value No. 12 Private Securities Investment Fund for 1,483,679 shares for CNY 19,999,992.92.

After the issuance, Liao Lei owns 7,430,637 shares, accounting for 2.53% stake; Guangzhou Ruisheng Private Securities Investment Management Partnership Enterprise (Limited Partnership) - Ruisheng No. 6 Private Securities Investment Fund owns 5,044,510 shares, accounting for 1.72% stake;